We also found that DSCAM-AS1 and AKT3 expression was downregulated, while miR-384 was upregulated in xenograft tumor of sh-DSCAM-AS1/LOVO group when compared to sh-NC/LOVO group (Figure 6E–6H). Here, DSCAM is linked to neoplasm.